Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.140
-0.100 (-8.06%)
At close: Mar 28, 2025, 4:00 PM
1.130
-0.010 (-0.88%)
After-hours: Mar 28, 2025, 7:59 PM EDT
PACB Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for PACB stock have an average target of 2.46, with a low estimate of 1.50 and a high estimate of 4.00. The average target predicts an increase of 115.79% from the current stock price of 1.14.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PACB stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Hold | 7 | 8 | 8 | 6 | 6 | 6 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 15 | 15 | 15 | 13 | 13 | 13 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Scotiabank | Scotiabank | Buy Maintains $6 → $2 | Buy | Maintains | $6 → $2 | +75.44% | Mar 25, 2025 |
Piper Sandler | Piper Sandler | Hold Reiterates $2.5 → $2 | Hold | Reiterates | $2.5 → $2 | +75.44% | Feb 20, 2025 |
Goldman Sachs | Goldman Sachs | Hold Maintains $1.75 → $1.5 | Hold | Maintains | $1.75 → $1.5 | +31.58% | Feb 18, 2025 |
Stephens & Co. | Stephens & Co. | Buy Reiterates $2.5 | Buy | Reiterates | $2.5 | +119.30% | Feb 18, 2025 |
Stephens & Co. | Stephens & Co. | Buy Reiterates $2.5 | Buy | Reiterates | $2.5 | +119.30% | Feb 14, 2025 |
Financial Forecast
Revenue This Year
164.98M
from 154.01M
Increased by 7.12%
Revenue Next Year
209.24M
from 164.98M
Increased by 26.83%
EPS This Year
-0.75
from -1.13
EPS Next Year
-0.59
from -0.75
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 174.4M | 254.4M | 306.6M | ||
Avg | 165.0M | 209.2M | 253.5M | ||
Low | 153.6M | 177.4M | 199.9M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 13.2% | 54.2% | 46.5% | ||
Avg | 7.1% | 26.8% | 21.2% | ||
Low | -0.3% | 7.5% | -4.5% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.64 | -0.32 | -0.19 | ||
Avg | -0.75 | -0.59 | -0.46 | ||
Low | -0.83 | -0.74 | -0.57 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.